Compare NTRA & KB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NTRA | KB |
|---|---|---|
| Founded | 2003 | 2008 |
| Country | United States | South Korea |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Commercial Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 39.1B | 38.3B |
| IPO Year | 2015 | 2008 |
| Metric | NTRA | KB |
|---|---|---|
| Price | $261.99 | $117.43 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 15 | 0 |
| Target Price | ★ $259.07 | N/A |
| AVG Volume (30 Days) | ★ 1.3M | 300.1K |
| Earning Date | 05-07-2026 | 04-23-2026 |
| Dividend Yield | N/A | ★ 2.31% |
| EPS Growth | ★ 0.65 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $210,939,000.00 | N/A |
| Revenue This Year | $18.08 | $18.22 |
| Revenue Next Year | $19.65 | $3.21 |
| P/E Ratio | ★ N/A | $9.90 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $131.81 | $76.31 |
| 52 Week High | $288.04 | $125.62 |
| Indicator | NTRA | KB |
|---|---|---|
| Relative Strength Index (RSI) | 52.98 | 55.57 |
| Support Level | $261.63 | $98.93 |
| Resistance Level | $288.04 | $119.71 |
| Average True Range (ATR) | 10.37 | 2.67 |
| MACD | -3.55 | -0.10 |
| Stochastic Oscillator | 23.31 | 40.50 |
Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.
KB Financial Group Inc. is a financial holding company in Korea. The company operations include Kookmin Bank, one of the commercial banks in Korea. The company's subsidiaries collectively engage in a broad range of businesses, including commercial banking, credit cards, asset management, non-life and life insurance, capital markets activities, and international banking and finance. The company's segments include the Banking business, Securities business, Non-life Insurance business, Credit card business, and Life Insurance business. The Group generates the majority of its revenue from the Banking business.